Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of patients with aggressive pseudomyxoma peritonei treated by cytoreductive surgery and intraperitoneal chemotherapy.
Arjona-Sanchez A, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, Ayllon Teran MD, Orti-Rodriguez R, Padial-Aguado AC, Medina-Fernández J, Ortega-Salas R, Pulido-Cortijo G, Gómez-España A, Rufián-Peña S. Arjona-Sanchez A, et al. World J Surg. 2013 Jun;37(6):1263-70. doi: 10.1007/s00268-013-2000-2. World J Surg. 2013. PMID: 23532601
Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC.
Medina Fernández FJ, Muñoz-Casares FC, Arjona-Sánchez A, Casado-Adam A, Gómez-Luque I, Garcilazo Arismendi DJ, Thoelecke H, Rufián Peña S, Briceño Delgado J. Medina Fernández FJ, et al. Ann Surg Oncol. 2015 Apr;22(4):1332-40. doi: 10.1245/s10434-014-4096-5. Epub 2014 Sep 19. Ann Surg Oncol. 2015. PMID: 25234021
Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Arjona-Sanchez A, Muñoz-Casares C, Ortega-Salas R, Casado-Adam A, Sanchez-Hidalgo JM, Rufián-Peña S. Arjona-Sanchez A, et al. Int J Hyperthermia. 2014 Sep;30(6):408-11. doi: 10.3109/02656736.2014.952251. Int J Hyperthermia. 2014. PMID: 25256894 Free article.
Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC, Medina-Fernández FJ, Arjona-Sánchez Á, Casado-Adam Á, Sánchez-Hidalgo JM, Rubio MJ, Ortega-Salas R, Muñoz-Villanueva MC, Rufián-Peña S, Briceño FJ. Muñoz-Casares FC, et al. Eur J Surg Oncol. 2016 Feb;42(2):224-33. doi: 10.1016/j.ejso.2015.11.006. Epub 2015 Nov 25. Eur J Surg Oncol. 2016. PMID: 26673283
"Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances".
Arjona-Sánchez A, Cadenas-Febres A, Cabrera-Bermon J, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, López-Andreu M, Briceño-Delgado J, Rufián-Peña S. Arjona-Sánchez A, et al. Eur J Surg Oncol. 2016 Jun;42(6):869-76. doi: 10.1016/j.ejso.2015.12.016. Epub 2016 Feb 11. Eur J Surg Oncol. 2016. PMID: 26898841
Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy.
Arjona-Sanchez A, Rufian-Peña S, Artiles M, Sánchez-Hidalgo JM, Casado-Adam Á, Cosano A, Thoelecke H, Ramnarine S, Garcilazo D, Briceño-Delgado J. Arjona-Sanchez A, et al. Int J Hyperthermia. 2018 Aug;34(5):570-577. doi: 10.1080/02656736.2018.1423708. Epub 2018 Jan 17. Int J Hyperthermia. 2018. PMID: 29298538 Free article.
36 results